EX-23.2 3 d709396dex232.htm EX-23.2 EX-23.2

Exhibit 23.2

Consent of Independent Registered Public Accounting Firm

The Board of Directors

Iterum Therapeutics plc:

We consent to the use of our report dated March 25, 2019 incorporated by reference herein.

/s/ KPMG

Dublin, Ireland

March 25, 2019